Rankin Danielle A, Katz Sophie E, Amarin Justin Z, Hayek Haya, Stewart Laura S, Slaughter James C, Deppen Stephen, Yanis Ahmad, Romero Yesenia Herazo, Chappell James D, Khankari Nikhil K, Halasa Natasha B
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt Epidemiology PhD Program, Vanderbilt University School of Medicine, Nashville, TN, USA.
Antimicrob Steward Healthc Epidemiol. 2024 Mar 6;4(1):e29. doi: 10.1017/ash.2024.24. eCollection 2024.
Evaluate the association between provider-ordered viral testing and antibiotic treatment practices among children discharged from an ED or hospitalized with an acute respiratory infection (ARI).
Active, prospective ARI surveillance study from November 2017 to February 2020.
Pediatric hospital and emergency department in Nashville, Tennessee.
Children 30 days to 17 years old seeking medical care for fever and/or respiratory symptoms.
Antibiotics prescribed during the child's ED visit or administered during hospitalization were categorized into (1) None administered; (2) Narrow-spectrum; and (3) Broad-spectrum. Setting-specific models were built using unconditional polytomous logistic regression with robust sandwich estimators to estimate the adjusted odds ratios and 95% confidence intervals between provider-ordered viral testing (ie, tested versus not tested) and viral test result (ie, positive test versus not tested and negative test versus not tested) and three-level antibiotic administration.
4,107 children were enrolled and tested, of which 2,616 (64%) were seen in the ED and 1,491 (36%) were hospitalized. In the ED, children who received a provider-ordered viral test had 25% decreased odds (aOR: 0.75; 95% CI: 0.54, 0.98) of receiving a narrow-spectrum antibiotic during their visit than those without testing. In the inpatient setting, children with a negative provider-ordered viral test had 57% increased odds (aOR: 1.57; 95% CI: 1.01, 2.44) of being administered a broad-spectrum antibiotic compared to children without testing.
In our study, the impact of provider-ordered viral testing on antibiotic practices differed by setting. Additional studies evaluating the influence of viral testing on antibiotic stewardship and antibiotic prescribing practices are needed.
评估在急诊科就诊或因急性呼吸道感染(ARI)住院的儿童中,医生开具的病毒检测与抗生素治疗实践之间的关联。
2017年11月至2020年2月的主动、前瞻性ARI监测研究。
田纳西州纳什维尔的儿科医院和急诊科。
30天至17岁因发热和/或呼吸道症状寻求医疗护理的儿童。
将儿童在急诊科就诊期间开具的或住院期间使用的抗生素分为以下几类:(1)未使用;(2)窄谱;(3)广谱。使用无条件多分类逻辑回归和稳健的三明治估计量构建特定环境模型,以估计医生开具的病毒检测(即检测与未检测)和病毒检测结果(即阳性检测与未检测以及阴性检测与未检测)与三级抗生素使用之间的调整比值比和95%置信区间。
共纳入4107名儿童并进行检测,其中2616名(64%)在急诊科就诊,1491名(36%)住院。在急诊科,接受医生开具病毒检测的儿童在就诊期间接受窄谱抗生素的几率比未检测的儿童降低了25%(调整后比值比:0.75;95%置信区间:0.54,0.98)。在住院环境中,医生开具病毒检测结果为阴性的儿童与未检测的儿童相比,接受广谱抗生素治疗的几率增加了57%(调整后比值比:1.57;95%置信区间:1.01,2.44)。
在我们的研究中,医生开具的病毒检测对抗生素使用的影响因环境而异。需要进一步开展研究,评估病毒检测对抗生素管理和抗生素处方实践的影响。